Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05704283 · ClinicalTrials.gov registry record · Early Phase 1
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
A Early Phase 1 study of Breast Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05704283 is a Early Phase 1 study of Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 55 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05704283, a Early Phase 1 study of Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
Conditions Studied
Interventions
- DEVICE Ultrasound Imaging
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2027-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05704283
The ClinicalTrials.gov registry entry for NCT05704283 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Imaging is the first listed.
NCT05704283 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05704283 about?
NCT05704283 is a clinical study titled "3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer". This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
What is the current status of trial NCT05704283?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 55 participants. The study started on 2023-02-14. Estimated completion is 2027-06-01.
What conditions does trial NCT05704283 study?
This clinical trial studies the following conditions: Breast Carcinoma.
What interventions are being tested in trial NCT05704283?
The interventions under investigation include: Ultrasound Imaging (DEVICE).
Who is sponsoring clinical trial NCT05704283?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05704283 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
RECRUITING · Early Phase 1
-
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
ACTIVE NOT RECRUITING · Early Phase 1
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
-
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
COMPLETED · Early Phase 1
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.